Potentially Inappropriate Medication Use Among Older Patients with Diabetes in a Chinese Community

Exp Clin Endocrinol Diabetes. 2023 Oct;131(10):548-553. doi: 10.1055/a-2123-0734. Epub 2023 Jul 4.

Abstract

Background: Potentially inappropriate medications (PIMs) are frequently prescribed to older people with diabetes. This study aimed to assess the prevalence of PIM use in older people with diabetes and identify potential risk factors influencing the development of PIM use.

Methods: This was a cross-sectional study conducted in an outpatient setting in Beijing, China, using Chinese criteria. The prevalence of PIM use, polypharmacy, and comorbidities in older adults with diabetes in an outpatient setting was measured. Logistic models were employed to investigate the association among polypharmacy, comorbidities, and PIM use.

Results: The prevalence of PIM use and polypharmacy was 50.1% and 70.8%, respectively. The most common comorbidities were hypertension (68.0%), hyperlipemia (56.6%), and stroke (36.3%), and the top three inappropriately used medications were insulin (22.0%), clopidogrel (11.9%), and eszopiclone (9.81%). Age (OR 1.025; 95% CI 1.009, 1.042), the number of diagnoses (OR 1.172; 95% CI 1.114, 1.232), coronary heart disease (OR 1.557; 95% CI 1.207, 2.009), and polypharmacy (OR 1.697; 95% CI 1.252, 2.301) were associated with PIM use.

Conclusions: Given the higher rate of PIM use among older adults with diabetes, strategies and interventions targeting this population are needed to minimize PIM use.

MeSH terms

  • Aged
  • Comorbidity
  • Cross-Sectional Studies
  • Diabetes Mellitus* / drug therapy
  • Diabetes Mellitus* / epidemiology
  • East Asian People
  • Humans
  • Inappropriate Prescribing
  • Polypharmacy
  • Potentially Inappropriate Medication List*